BlackRock Maintains 15.6% Stake in Tandem Diabetes Care (TNDM)
Ticker: TNDM · Form: SC 13G/A · Filed: 2024-01-23T00:00:00.000Z
Sentiment: bullish
Topics: institutional-ownership, passive-investment, amendment, healthcare
TL;DR
**BlackRock still owns 15.6% of TNDM, a bullish sign for the stock.**
AI Summary
BlackRock Inc. has updated its ownership stake in Tandem Diabetes Care Inc. (TNDM) as of December 31, 2023, filing an amendment to its Schedule 13G. This filing indicates BlackRock's passive investment in the medical device company, holding 10,035,765 shares, which represents 15.6% of the common stock. This matters to investors because BlackRock is a major institutional investor, and its continued significant stake signals confidence in Tandem Diabetes Care's long-term prospects, potentially influencing other investors.
Why It Matters
BlackRock's substantial, continued ownership in Tandem Diabetes Care Inc. suggests institutional confidence in the company's future, which can be a positive signal for current and prospective shareholders.
Risk Assessment
Risk Level: low — This filing indicates a passive, significant institutional ownership, which generally reduces volatility and adds stability to the stock.
Analyst Insight
A smart investor would view BlackRock's continued significant stake as a vote of confidence, potentially indicating long-term stability and growth prospects for Tandem Diabetes Care Inc., and might consider further research into the company's fundamentals.
Key Numbers
- 10,035,765 — Shares Owned (Represents BlackRock's total beneficial ownership in Tandem Diabetes Care Inc.)
- 15.6% — Percentage of Class (Indicates BlackRock's significant stake in Tandem Diabetes Care Inc.'s common stock.)
- 875372203 — CUSIP Number (Identifies the specific class of securities (Common Stock) of Tandem Diabetes Care Inc.)
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Tandem Diabetes Care Inc. (company) — the subject company whose securities are being reported
- 10,035,765 (dollar_amount) — number of shares beneficially owned by BlackRock Inc.
- 15.6% (dollar_amount) — percentage of class owned by BlackRock Inc.
- December 31, 2023 (date) — the date of the event requiring this filing
Forward-Looking Statements
- BlackRock will maintain a significant, passive stake in Tandem Diabetes Care Inc. throughout 2024. (BlackRock Inc.) — high confidence, target: December 31, 2024
FAQ
Who is the reporting person in this SC 13G/A filing?
The reporting person is BlackRock, Inc., as stated in item (1) of the cover page and the 'FILED BY' section of the filing.
What is the subject company whose securities are being reported?
The subject company is TANDEM DIABETES CARE INC, as indicated in the 'SUBJECT COMPANY' section and the 'Name of Issuer' on the Schedule 13G.
What percentage of Tandem Diabetes Care Inc.'s common stock does BlackRock Inc. beneficially own as of the filing date?
As of December 31, 2023, BlackRock Inc. beneficially owns 15.6% of Tandem Diabetes Care Inc.'s common stock, as detailed in the filing.
What is the CUSIP number for the class of securities reported in this filing?
The CUSIP number for the Common Stock of Tandem Diabetes Care Inc. is 875372203, as listed on the cover page of the Schedule 13G.
What was the date of the event which required the filing of this statement?
The date of the event which required the filing of this statement was December 31, 2023, as specified on the Schedule 13G.
From the Filing
0001086364-24-001333.txt : 20240123 0001086364-24-001333.hdr.sgml : 20240123 20240123115227 ACCESSION NUMBER: 0001086364-24-001333 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240123 DATE AS OF CHANGE: 20240123 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87718 FILM NUMBER: 24551314 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us8753722037_012324.txt us8753722037_012324.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) TANDEM DIABETES CARE INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 875372203 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 875372203 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 8923523 (6) Shared voting power 0 (7) Sole dispositive power 9259187 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 9259187 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 14.2% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- TANDEM DIABETES CARE INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 12400 HIGH BLUFF DRIVE San Diego CA 92130 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or,